Hong Kong Luxury Stock News

As the Bank of Japan raises interest rates to levels not seen in three decades and China's economic indicators reveal mixed signals, investors are closely monitoring the Asian markets for potential opportunities. In this environment, dividend stocks can offer a more stable income stream, making them an attractive option for those looking to navigate uncertain economic conditions.

The Solartech International Holdings Limited ( HKG:1166 ) share price has done very well over the last month, posting...

Reliance Global Holdings Limited ( HKG:723 ) shares have had a really impressive month, gaining 44% after a shaky...

Chow Sang Sang Holdings International Limited's ( HKG:116 ) price-to-earnings (or "P/E") ratio of 7.3x might make it...

Despite an already strong run, ITC Properties Group Limited ( HKG:199 ) shares have been powering on, with a gain of...

There wouldn't be many who think Great Eagle Holdings Limited's ( HKG:41 ) price-to-sales (or "P/S") ratio of 1x is...

Shareholders appeared unconcerned with Asia Commercial Holdings Limited's ( HKG:104 ) lackluster earnings report last...

The Asian markets have been navigating a complex landscape, with significant developments such as the Bank of Japan raising its benchmark interest rate to the highest level in 30 years. Against this backdrop, penny stocks—though an older term—remain a relevant area for investment, particularly among smaller or newer companies that might offer unique growth opportunities. In light of current market conditions, we explore several penny stocks that exhibit financial strength and potential for...

When close to half the companies in Hong Kong have price-to-earnings ratios (or "P/E's") above 13x, you may consider...

Earlier in 2025, JD Health International expanded its “retail pharmacy + online medical service” model, reinforcing its position as China’s largest online B2C retail pharmacy while rolling out AI-powered tools such as the “Beijing Medicine Thousand Questions” medical model and intelligent assistants. By combining round-the-clock online consultations, specialized medical services, and new AI-driven products, JD Health is deepening its integrated healthcare ecosystem and broadening how users...

The latest move at CSPC Pharmaceutical Group (SEHK:1093) blends leadership change with pipeline progress, as the company installs a new CEO and secures trial approval for its SYH2085 influenza candidate. See our latest analysis for CSPC Pharmaceutical Group. The market seems to like this mix of fresh leadership and R&D momentum, with CSPC Pharmaceutical Group's 1 day share price return of 7.64 percent and 7 day share price return of 20.65 percent pushing the stock to HK$8.88. This backs up an...

Zhongsheng Group Holdings (SEHK:881) just overhauled a key part of its governance, with long serving audit committee chair Ying Wei stepping down and tax specialist Bai Fengjiu taking over leadership of audit oversight. See our latest analysis for Zhongsheng Group Holdings. The governance refresh comes after a tough stretch, with a 90 day share price return of negative 19.33 percent and a three year total shareholder return of negative 67.17 percent. Investors will be watching to see if...

ANTA Sports Products (SEHK:2020) just sharpened its governance playbook by formally revising the mandate of its Sustainability Committee to tighten board oversight of ESG strategy, risk management, and disclosure across the group. See our latest analysis for ANTA Sports Products. That stronger ESG oversight comes as the share price sits at HK$82.25, with an 8.01 percent year to date share price return but a weaker 5 year total shareholder return of negative 24.19 percent. This suggests long...

Key Insights The considerable ownership by private companies in CGN Mining indicates that they collectively have a...

Key Insights Significant control over Maanshan Iron & Steel by private companies implies that the general public has...

Alibaba Health Information Technology Limited has announced that, effective December 15, 2025, chief executive officer Shen Difan has also been appointed Chairman and head of the Nomination Committee, while former Chairman and non-executive Director Zhu resigned for personal reasons. This move consolidates leadership roles in one individual and formally departs from Hong Kong’s corporate governance code provision that encourages separating the chairman and CEO positions, putting board...

In December 2025, Nongfu SPRING Co., Ltd. announced renewed three-year framework agreements with Yangshengtang Group covering basic R&D, testing services, and purchasing arrangements effective from January 1, 2026 to December 31, 2028. The renewed R&D and test service framework centralizes intellectual property ownership for work products with Nongfu’s group, highlighting how the company is formalizing control over innovation supporting its expanding beverage portfolio. With new R&D...

Amid recent developments in Asia's financial landscape, including the Bank of Japan raising its benchmark interest rate to a 30-year high and mixed signals from China's economic indicators, investors are keenly observing opportunities for value in the region. In this context, identifying stocks that are trading at a discount can be particularly appealing, as they may offer potential upside when market conditions stabilize or improve.

LVGEM (China) Real Estate Investment Company Limited ( HKG:95 ) shareholders should be happy to see the share price up...

If you're looking at a mature business that's past the growth phase, what are some of the underlying trends that pop...

Giant Biogene Holding (SEHK:2367) has kicked off a sizeable share repurchase program, with approval to buy back up to 10% of its share capital. This move puts capital allocation firmly in the spotlight for investors. See our latest analysis for Giant Biogene Holding. The buyback comes after a tough stretch, with a 90 day share price return of negative 41.32 percent, but a recent 4.40 percent 7 day share price return around HK$36.06 hints that sentiment may be stabilising rather than sliding...

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...